GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (NYSE:DVA) » Definitions » Cyclically Adjusted Revenue per Share

DaVita (DaVita) Cyclically Adjusted Revenue per Share : $95.08 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is DaVita Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

DaVita's adjusted revenue per share for the three months ended in Dec. 2023 was $33.907. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $95.08 for the trailing ten years ended in Dec. 2023.

During the past 12 months, DaVita's average Cyclically Adjusted Revenue Growth Rate was 10.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 14.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of DaVita was 24.40% per year. The lowest was 9.30% per year. And the median was 14.80% per year.

As of today (2024-04-27), DaVita's current stock price is $133.51. DaVita's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $95.08. DaVita's Cyclically Adjusted PS Ratio of today is 1.40.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DaVita was 2.37. The lowest was 0.78. And the median was 1.47.


DaVita Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for DaVita's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Cyclically Adjusted Revenue per Share Chart

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.00 63.65 74.63 86.30 95.08

DaVita Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.30 89.16 91.59 93.88 95.08

Competitive Comparison of DaVita's Cyclically Adjusted Revenue per Share

For the Medical Care Facilities subindustry, DaVita's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's Cyclically Adjusted PS Ratio falls into.



DaVita Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DaVita's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=33.907/129.4194*129.4194
=33.907

Current CPI (Dec. 2023) = 129.4194.

DaVita Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 14.079 99.695 18.277
201406 14.639 100.560 18.840
201409 14.969 100.428 19.290
201412 15.292 99.070 19.977
201503 15.408 99.621 20.017
201506 15.784 100.684 20.289
201509 16.270 100.392 20.974
201512 -1.250 99.792 -1.621
201603 17.223 100.470 22.186
201606 17.869 101.688 22.742
201609 18.026 101.861 22.903
201612 13.721 101.863 17.433
201703 13.474 102.862 16.953
201706 13.915 103.349 17.425
201709 14.446 104.136 17.953
201712 15.046 104.011 18.722
201803 15.670 105.290 19.261
201806 16.582 106.317 20.185
201809 17.023 106.507 20.685
201812 16.952 105.998 20.698
201903 16.447 107.251 19.847
201906 17.043 108.070 20.410
201909 19.195 108.329 22.932
201912 22.239 108.420 26.546
202003 22.390 108.902 26.608
202006 23.213 108.767 27.621
202009 23.590 109.815 27.801
202012 25.108 109.897 29.568
202103 24.769 111.754 28.684
202106 26.175 114.631 29.552
202109 26.751 115.734 29.914
202112 28.093 117.630 30.909
202203 28.035 121.301 29.911
202206 29.935 125.017 30.989
202209 31.617 125.227 32.676
202212 31.748 125.222 32.812
202303 31.062 127.348 31.567
202306 32.118 128.729 32.290
202309 33.191 129.860 33.079
202312 33.907 129.419 33.907

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


DaVita  (NYSE:DVA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

DaVita's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=133.51/95.08
=1.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of DaVita was 2.37. The lowest was 0.78. And the median was 1.47.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


DaVita Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of DaVita's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (DaVita) Business Description

Industry
Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Executives
Christopher Michael Berry officer: Chief Accounting Officer C/O SONDER HOLDINGS INC., 101 15TH ST., SAN FRANCISCO CA 94103
Kathleen Alyce Waters officer: Chief Legal Officer C/O DAVITA INC., 2000 16TH STREET, DENVER CO 80202
Wendy Lee Schoppert director 6105 TRENTON LANE NORTH, MINNEAPOLIS MN 55442
Phyllis R Yale director
Javier Rodriguez officer: Chief Executive Officer, DKC 601 HAWAII ST., EL SEGUNDO CA 90245
Barbara J Desoer director CITIGROUP INC., 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10013
James O Hearty officer: Chief Compliance Officer 2000 16TH STREET, DENVER CO 80202
Charles Berg director, officer: Executive Chair, DMG 48 MONROE TURNPIKE, TRUMBULL CT 06611
John M Nehra director 1119 ST PAUL ST, BALTIMORE MD 21202
Adam H Schechter director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Michael David Staffieri officer: Chief Operating Officer, DKC 2000 16TH STREET, DENVER CO 80202
Jason M. Hollar director 3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
Paula A Price director ONE CVS DRIVE, WOONSOCKET RI 02895
Pamela M Arway director 601 HAWAII ST., EL SEGUNDO CA 90245
Gregory J. Moore director 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601

DaVita (DaVita) Headlines

From GuruFocus

Q4 2019 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2020 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2019 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2020 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2023 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024